Evidence map›Paper›PMID 42865761›Full record

ReviewJournal of thoracic disease2026

Echocardiography-based multimodal models for thromboembolic risk prediction in atrial fibrillation: a narrative review.

Lei Liu, Aiyue Chen, Linqi Liu, Pakezhati Maimaitijiang, Xinyi Wang, Lihui Zheng

Abstract readReview
In one paragraph

Review in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lei LiuCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, National Key Laboratory, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.ORCID https://orcid.org/0000-0002-5416-0099
Aiyue ChenCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, National Key Laboratory, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Linqi LiuCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, National Key Laboratory, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Pakezhati MaimaitijiangCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, National Key Laboratory, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xinyi WangCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, National Key Laboratory, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lihui ZhengCardiac Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, National Key Laboratory, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: The congestive heart failure, hypertension, age ≥75 years, diabetes, stroke, vascular disease, age 65-74 years, sex category (CHA Methods: A comprehensive literature search was conducted using relevant electronic databases (e.g., PubMed, Web of Science and Embase) to identify studies focusing on echocardiographic parameters, AF, and thromboembolic risk prediction models published up to May 2026. Key Content and Findings: Echocardiographic parameters evaluating the left atrium and left atrial appendage (LAA; size, function, and morphology) have emerged as significant predictors of both prevalent thrombus formation and future thromboembolic events. This review details these key parameters and critically assesses various multimodal approaches, including those combining clinical-echocardiographic scores with artificial intelligence (AI) techniques. Importantly, these models demonstrate enhanced predictive accuracy for specific clinical endpoints over traditional clinical scores. Conclusions: Utilizing a multimodal approach provides a promising supplementary tool for refined risk assessment, rather than replacing guideline-based anticoagulation decisions. Future directions should focus on standardizing echocardiographic measurements, expanding the use of AI for automated analysis, and conducting prospective interventional trials to confirm clinical benefit.

Indexed as

Atrial fibrillation (AF)echocardiographyrisk predictionstrokethrombus

Identifiers

PMID42865761
PMCPMC13655801

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.